Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Myelodysplastic Syndromes
×
sabatolimab
×
Clear all
Filters
3
NCT04266301
2026-01-13
STIMULUS-MDS2
Novartis
Phase 3
Terminated
530 enrolled
29 charts